Can-Fite BioPharma Ltd. (CANF) stock
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.49−0.06 (-3.87%)
Close on Nov 12, 2026Market cap $1.95MP/E –Yield –
Can-Fite BioPharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Can-Fite BioPharma's enterprise value was $329.95K on Nov 11, 2026, against -$1.82M a year earlier. Over the last 5 years it ranged from -$3.81M to $29.09M, with a median of $4.38M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $329.95K | – |
| 2025 | Dec 31, 2025 | -$3.81M | -188.1% |
| 2024 | Dec 31, 2024 | $4.33M | -21.7% |
| 2023 | Dec 29, 2023 | $5.52M | -63.1% |
| 2022 | Dec 30, 2022 | $14.96M | +2.2% |
| 2021 | Dec 31, 2021 | $14.64M | -4.6% |
| 2020 | Dec 31, 2020 | $15.34M | – |
| 2019 | Dec 31, 2019 | -$3.92M | -126.8% |
| 2018 | Dec 31, 2018 | $14.65M | +18.0% |
| 2017 | Dec 29, 2017 | $12.42M | – |
| 2016 | Dec 30, 2016 | -$16.89M | – |
See a number that looks wrong?